ASX-listed medications adherence technology developer MedAdvisor is hoping to raise $45 million to fund the acquisition of US-based patient adherence and engagement solutions vendor Adheris Health and expand its operations internationally.

MedAdvisor has partnered with Adheris since 2019 to offer digital adherence programs to Adheris Health’s pharmaceutical clients and across its retail pharmacy network.